Natural Killer Cells Therapeutics Market Volume Analysis, Segments, Value Share and Key Trends 2018-2026

A Comprehensive research study conducted by KD Market Insights on " Natural Killer Cells Therapeutics Market - By Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2026" report offers extensive and highly detailed historical, current and future market trends in the Global and regional/market. The Natural Killer Cells Therapeutics Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.

The global natural killer cell therapeutics market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2026, registering a CAGR of 17.4% from 2019 to 2026.

The growth of the global natural killer cell therapeutics market is driven by rise in use of NK cells to treat cancer, infections, and liver diseases. Moreover, NK cells play vital role in tumor immune surveillance, which has significantly boosted their adoption across the globe. In addition, rise in awareness among the population regarding various immunotherapies and increase in R&D for the development of bi-specific antibody for engaging NK cells to eliminate tumor cells propel the global natural killer cell therapeutics market growth. However, lack of specificity and poor in-vivo survival of the cells limit the growth of the market. Furthermore, higher costs associated with the therapies and adverse side effects are expected to hamper the market growth in the coming years. Conversely, significant surge in R&D activities toward development of immunotherapy in developing economies is anticipated to offer lucrative opportunities for the market.

Request for Sample @ https://www.kdmarketinsights.com/sample/5441 
 
The global natural killer cell therapeutics market is segmented based on therapeutics, application, end user, and region. Depending on therapeutics, the natural killer cells therapeutics market is classified into NK cell therapies and NK cell directed antibodies. By application, it is categorized into cancer, gastrointestinal diseases, immunoproliferative disorders, and others. On the basis of end user, it is segregated into hospitals, research centers & institutes, and others. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
- The global natural killer cell therapeutics market size and estimations are based on a comprehensive analysis of key developments.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments
By Therapeutics
- NK Cell Therapies
- NK Cell Directed Antibodies

By Application
- Cancer
- Gastrointestinal Diseases
- Immunoproliferative Disorders
- Others

By End User
- Research Centers & Institutes
- Hospitals
- Others

By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

The key players profiled in this report are as follows:
- Affimed N.V.
- Celgene Corporation
- Fate Therapeutics
- Fortress Biotech
- Glycostem Therapeutics BV
- Innate Pharma S.A.
- Nantkwest Inc.
- Nkarta Therapeutics, Inc.
- NKT Therapeutics Inc.
- Ziopharm Oncology Inc.

Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/natural-killer-cells-therapeutics-market-amr

Table of Contents:
 
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in incidence of cancer across the globe
3.5.1.2. Increase in government expenditure on healthcare
3.5.1.3. Surge in awareness regarding immunotherapy
3.5.2. Restraints
3.5.2.1. High cost of cancer immunotherapy treatment
3.5.2.2. Stringent government regulations toward approval of immunotherapy
3.5.3. Opportunity
3.5.3.1. Surge in R&D activities toward the development of immunotherapy
3.6. Government regulatory scenerio
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.6.4. Thailand
3.6.5. Singapore
3.6.6. Malaysia
3.6.7. Mexico
3.6.8. Australia

CHAPTER 4: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY THERAPEUTICS
4.1. Overview
4.1.1. Market and forecast
4.2. Natural killer cell therapies
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.3.1. CNDO-109
4.2.3.2. oNKord
4.2.3.3. Natural Killer Cells
4.2.3.4. Others
4.3. NK cell-directed antibodies
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.3.1. MOGAMULIZUMAB
4.3.3.2. Lirilumab
4.3.3.3. AFM13
4.3.3.4. NKTT 120
4.3.3.5. Others
CHAPTER 5: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by region
5.2. Cancer
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Gastrointestinal diseases
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Immunoproliferative disorders
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country

CHAPTER 6: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY END USER
6.1. Overview
6.1.1. Market and forecast
6.2. Research centers and institutes
6.2.1. Market and forecast, by region
6.2.2. Market analysis, by country
6.3. Hospitals and clinics
6.3.1. Market and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: NATURAL KILLER CELL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by therapeutics
7.2.3. Market size and forecast, by application
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by therapeutics
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by therapeutics
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.7. Mexico market size and forecast, by therapeutics
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by therapeutics
7.3.3. Market size and forecast, by application
7.3.4. Market size and forecast, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. UK market size and forecast, by therapeutics
7.3.5.2. UK market size and forecast, by application
7.3.5.3. UK market size and forecast, by end user
7.3.5.4. Germany market size and forecast, by therapeutics
7.3.5.5. Germany market size and forecast, by application
7.3.5.6. Germany market size and forecast, by end user
7.3.5.7. France market size and forecast, by therapeutics
7.3.5.8. France market size and forecast, by application
7.3.5.9. France market size and forecast, by end user
7.3.5.10. Italy market size and forecast, by therapeutics
7.3.5.11. Italy market size and forecast, by application
7.3.5.12. Italy market size and forecast, by end user
7.3.5.13. Spain market size and forecast, by therapeutics
7.3.5.14. Spain market size and forecast, by application
7.3.5.15. Spain market size and forecast, by end user
7.3.5.16. Rest of Europe market size and forecast, by therapeutics
7.3.5.17. Rest of Europe market size and forecast, by application
7.3.5.18. Rest of Europe market size and forecast, by end user
Continue….
 
Check for Discount @ https://www.kdmarketinsights.com/discount/5441

Contact Us:
 
KD Market Insights
90 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: info@kdmarketinsights.com 
Website: www.kdmarketinsights.com 
Read More News: https://consumersgoods745245330.wordpress.com/
https://ictindustry9.blogspot.com/ 

About Us:

KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends. Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Research, you always have the choice of getting customized report free of cost (up to 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 500 companies and leading advisory firms.

This release was published on openPR.